8 results
Optimal glycemic control is fundamental to the management of diabetes.

A1C% measurement approximately every 3 months determines
fundamental to the management ... A1C% measurement ... The frequency of A1C ... 2 diabetes, an A1C ... #table
Cardiac Valve Replacement - Anticoagulation INR Targets and Antiplatelet by Valve Type

Bioprosthetic valves require at least
Anticoagulation INR Targets ... monotherapy (2017 AHA/ACC ... valve (2017 AHA/ACC ... #Management #Cardiology ... #DOAC #Table #Replacement
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
summarizes the A1C ... pharmacotherapy #table ... #comparison #management ... endocrinology #treatment
Table of Common Rate Control Agents via AHA/ACC/HRS Guidelines #Management #Pharm #EM #IM #Cardiology #Afib #Common
Table of Common ... Agents via AHA/ACC ... HRS Guidelines #Management ... #Pharm #EM #IM ... #RateControl #Table
JNC8 blood pressure goals for the treatment of hypertension are a lot simpler than they may
goals for the treatment ... from the 2017 ACC ... bloodpressure #goals #targets ... #treatment #hypertension ... #management #guidelines
Diabetic Myonecrosis (Diabetic Muscle Infarction)
 • Spontaneous ischemic necrosis of skeletal muscle (anterior thigh or calf)
pain • Mean AIC ... weeks with above treatment ... months - CMC IM ... Infarction #diagnosis #management
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
Prevention or Treatment ... APC denotes antigen-presenting ... mTOR mammalian target ... Pathophysiology #IM
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Failure (HFrEF) Treatment ... them up to the target ... recommended by the ACC ... #Pharmacology #Management ... #Treatment #StageC